// App-Quantinova.ai

: Recurrent CMV Viremia Portends Poor Prognosis and Results in Significant Resource Utilization in Patients with Poor Graft Function Post Allogeneic Stem Cell Transplantation

Researchers

Presenter

  • Ashvind Anand Prabahran

Principal Investigators

  • Lynette C.Y. Chee

  • Rachel M Koldej

  • Michelle K Yong

  • David Ritchie

Medical Centers

  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

  • ACRF Translational Research Laboratory, The Royal Melbourne Hospital, Parkville, Australia

  • Department of Medicine, The University of Melbourne, Parkville, Australia

  • Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia

  • Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • ST100

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A